Uploaded October 2019 | Updated September 2026, 2 weeks ago
The discovery and development of a breakthrough anti-cancer drug has seen four senior scientists from the Walter and Eliza Hall Institute of Medical Research win the 2019 Prime Minister’s Prize for Innovation.
Associate Professor Peter Czabotar, Professor David Huang, Professor Guillaume Lessene and Professor Andrew Roberts were recognised for their roles in the discovery and development of the anti-cancer drug venetoclax. The medicine is used to treat chronic lymphocytic leukaemia (CLL), the most common leukaemia diagnosed in Australia.
The discovery and development of a breakthrough anti-cancer drug has seen four senior scientists from the Walter and Eliza Hall Institute of Medical Research win the 2019 Prime Minister’s Prize for Innovation.
Associate Professor Peter Czabotar, Professor David Huang, Professor Guillaume Lessene and Professor Andrew Roberts were recognised for their roles in the discovery and development of the anti-cancer drug venetoclax. The medicine is used to treat chronic lymphocytic leukaemia (CLL), the most common leukaemia diagnosed in Australia.
